Under this scenario, we hypothesized that the transfer of EV miRNAs between EGFR-mutant and wild-type cancer cells mediates the response of EGFR-TKI in heterogeneous EGFR-mutant NSCLC. The gene discussed is EGFR; the disease is cancer.